Status:

COMPLETED

EEG Detection of Delirium

Lead Sponsor:

Centre hospitalier de l'Université de Montréal (CHUM)

Collaborating Sponsors:

TransMedTech Institute

Conditions:

Post Operative Delirium

Eligibility:

All Genders

65-120 years

Phase:

NA

Brief Summary

VEEGix is a portable device developed by NeuroServo for simplifying electroencephalograms at the bedside. It is an easy-to-use device that only requires the operator to place an adhesive strip of elec...

Eligibility Criteria

Inclusion

  • 65 years and older
  • Had a orthopedic or digestive surgery
  • Good undersanding of French or English
  • Consent to participate in the study

Exclusion

  • History of seizure or epilepsia
  • Structural brain damage
  • intelectual deiciency
  • Severe major neurocognitive disorder
  • incapacity to respond to the questionnaire
  • Hospitalised in intensive care or intubated

Key Trial Info

Start Date :

April 5 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 30 2023

Estimated Enrollment :

234 Patients enrolled

Trial Details

Trial ID

NCT04797052

Start Date

April 5 2021

End Date

January 30 2023

Last Update

March 30 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Centre Hospitalier de l'Université de Montréal

Montreal, Quebec, Canada